|
|
Office Locations:
|
500 Second St., Suite 200
San Francisco, CA 94107
| |
|
|
|
|
Information Technology
Life Sciences & Healthcare
Software & Internet
|
|
|
DCVC (Data Collective) backs entrepreneurs applying deep tech to transform giant industries. DCVC and its principals have supported brilliant people changing global-scale businesses for over twenty years, helping create tens of billions of dollars of value. DCVC focuses on Seed and Series A companies, and growth stage opportunities within its own portfolio.
|
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
COMPANY STAGE | REVENUE |
Venture Capital | |
Seed Stage (includes "pre-seed," or concept stage) | No Revenue |
Early Stage | Minimal Revenue |
Growth Stage (also called Mid-stage) | $2M-$7M |
Expansion Stage (also called Late-stage) | $7M and greater |
Private Equity | |
Lower Middle Market | $10M-$249M |
Middle Market | $250M-$499M |
Upper Middle Market | $500M-$1B |
Large Cap | >$1B |
|
|
|
|
|
Name | |
| |
Title | |
|
Dr. John Hamer | |
| |
Managing Partner | |
Dr. Kiersten Stead | |
| |
Managing Partner | |
James Hardiman | |
| |
Partner | |
Kelly Chen | |
| |
Partner | |
Matthew Ocko | |
| |
Managing Partner | |
|
|
|
Date
|
Name
|
State
|
Amount
|
Stage
|
02/29/2024
|
Fervo Energy
|
TX
|
$244,000,000
|
Venture
|
02/15/2024
|
Freenome
|
CA
|
$254,000,000
|
Venture
|
12/15/2023
|
Totus Medicines
|
CA
|
$66,000,000
|
Series B
|
12/13/2023
|
Fourth Power
|
MA
|
$19,000,000
|
Series A
|
10/17/2023
|
Reality Defender
|
NY
|
$15,000,000
|
Series A
|
08/29/2023
|
CH4 Global
|
CA
|
$29,000,000
|
Series B
|
07/27/2023
|
Proprio
|
WA
|
$43,000,000
|
Series B
|
06/22/2023
|
Kanvas Biosciences
|
NY
|
$12,000,000
|
Pre-Series A
|
|
|
|
|
|